The maple syrup to reduce the use of antibiotics?

A concentrated extract of maple syrup makes bacteria that cause more prone to antibiotics, according to laboratory experiments by researchers at McGill University. The findings suggest that combining the maple syrup extract with common antibiotics can increase the sensitivity of germs, leading to reduced use of antibiotics. [...]
The findings suggest that combining the maple syrup extract with common antibiotics can increase the sensitivity of germs, leading to reduced use of antibiotics. Overuse of antibiotics promotes the display of drug - resistant bacteria, which has become a major public-health concern worldwide.
Pro-search team. Natalie Tufenkji at the McGill Chemical Engineering Department has prepared a concentrated extract of maple syrup, which consists mainly of phenolic compounds. The maple syrup, made from the maple tree in North America, is a rich source of phenolic compounds.

Researchers tested the effect of extracts in the laboratory in variations of certain bacteria causing infections, including E.col and Proteus Mirabilis (a common cause of urinary lesion infection). Alone, the extract was very poor in fighting bacteria.
But the maple syrup extract was especially effective when applied in combination with antibiotics. Extract also acted synergyly with antibiotics in the destruction of resistance communities known as biofilma, which are common in hard-treated infections, such as urinary leafy infections.
We'll have to run vivo (in living organisms), and eventually clinical trials, before we can say what effect it would have on people”, Tufencji says. “But findings suggest a potentially simple and effective approach to reducing the use of antibiotics. I can see the extract of maple syrup finally, for example, in antibiotics capsules. ”
Scientists also found that the extract affects the expression of bacteria genes, suppressing a number of genes related to antibiotics and virulences.
All samples of the maple syrup used in the study were purchased on local markets in Montreal, then frozen until the start of each experiment, which included a series of steps to produce fenol-rich extracts.
Tufencji, leader of Canada Research Chair in Biocoloids and Surfaces, has also studied the potential for boronica derivatives to combat bacteria that cause infection. The new research has also been jointly drafted by academic colleagues Vimal Maturia and Zeinab Hosseyinidoust. /Telegraphy/












